Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing 48824.
Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing 48824.
J Dairy Sci. 2019 Oct;102(10):9165-9175. doi: 10.3168/jds.2018-16186. Epub 2019 Aug 1.
The objective of this field trial was to reduce bovine leukemia virus (BLV) transmission and prevalence in commercial dairy herds using proviral load (PVL) and lymphocyte count (LC) measurements as indicators of the most infectious animals for culling or segregation. Bovine leukemia virus causes lymphoma in <5% of infected cattle, and increased lymphocyte counts (lymphocytosis) in about one-third. Recent research has shown that dairy cows infected with BLV have altered immune function associated with decreases in milk production and lifespan. Recent findings show that a minority of infected cattle have PVL concentrations in blood and other body fluids of over 1,000 times that of other infected cattle. In combination with a high LC, these animals are thought to be responsible for most transmission of BLV in a herd. Milk or blood samples from adult cows in our 3 Midwestern dairy farm field trials were tested semiannually with ELISA for BLV antibodies, and ELISA-positive cattle were then retested using a blood LC and a quantitative PCR test for PVL to identify the animals presumed to be most infectious. Herd managers were encouraged to consider PVL and LC status when making cull decisions, and to segregate cows with the highest PVL and LC from their BLV ELISA-negative herd mates where possible. After 2 to 2.5 yr of this intervention, the incidence risk of new infections decreased in all 3 herds combined, from 13.8 to 2.2, and the overall herd prevalence decreased in all 3 herds combined from 62.0 to 20.7%, suggesting that this approach can efficiently reduce BLV transmission as well as prevalence. This is encouraging, because a very low prevalence of BLV infection would make it economically feasible to cull the remaining ELISA-positive cattle, as was achieved in national eradication programs in other countries decades ago.
本现场试验的目的是通过前病毒载量 (PVL) 和淋巴细胞计数 (LC) 测量来减少商业奶牛群中的牛白血病病毒 (BLV) 传播和流行,以此作为淘汰或隔离最具传染性动物的指标。BLV 可导致 <5% 的感染牛发生淋巴瘤,约三分之一的牛会出现淋巴细胞计数 (淋巴细胞增多症) 升高。最近的研究表明,感染 BLV 的奶牛的免疫功能发生改变,导致产奶量和寿命下降。最近的研究结果表明,少数受感染的奶牛血液和其他体液中的 PVL 浓度是其他受感染奶牛的 1000 多倍。这些动物的 LC 较高,被认为是导致牛群中 BLV 传播的主要原因。我们在中西部 3 个奶牛场的现场试验中,每半年用 ELISA 法对成年奶牛的牛奶或血液样本进行 BLV 抗体检测,对 ELISA 阳性的奶牛再用 LC ELISA 和定量 PCR 法检测 PVL,以确定被认为最具传染性的动物。鼓励牧场管理者在淘汰决策时考虑 PVL 和 LC 状态,并尽可能将 PVL 和 LC 最高的奶牛与 BLV ELISA 阴性的同群奶牛隔离。在进行了 2 至 2.5 年的干预后,所有 3 个牛群的新感染发病率均降低,从 13.8%降至 2.2%,所有 3 个牛群的总体流行率均降低,从 62.0%降至 20.7%,这表明该方法可有效地减少 BLV 传播和流行。这令人鼓舞,因为 BLV 感染的低流行率将使淘汰剩余的 ELISA 阳性牛在经济上可行,正如几十年前其他国家的国家根除计划所实现的那样。